Pfizer Inc.
Pfizer Inc., doing business as Pfizer and its subsidiaries, is a global pharmaceutical corporation that plays a significant role in supplying medical products and services to the U.S. federal government. As one of the world's largest pharmaceutical companies, Pfizer develops and produces a wide range of medicines and vaccines for various medical disciplines, including immunology, oncology, cardiology, endocrinology, and neurology. Through its federal contracts, Pfizer primarily provides pharmaceutical products, including prescription medications, vaccines, and other critical medical supplies to support healthcare initiatives across multiple government agencies.
Pfizer's recent prime contract awards have primarily been with the Defense Logistics Agency Troop Support Medical, supplying a diverse array of pharmaceutical products. These include controlled substances such as fentanyl, morphine, and midazolam; antibiotics like penicillin and azithromycin; and other critical medications such as tranexamic acid, methylprednisolone, and various injectable solutions. The company has also provided vaccines and other immunological products to agencies such as the Centers for Disease Control and Prevention. Most of Pfizer's contracts are awarded without set-aside designations, reflecting its status as a large corporation. While Pfizer primarily serves as a prime contractor, it has also acted as a subcontractor to other medical supply companies, such as Cardinal Health 200, LLC, providing medical and surgical equipment or supplies.
Pfizer holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies. A major IDV is a Federal Supply Schedule contract with the Department of Veterans Affairs, valued at $7.31 billion, which allows Pfizer to provide a comprehensive range of pharmaceutical products and services to various government entities through June 2029. This contract enables Pfizer to supply a diverse array of medical products, including prescription medications, vaccines, and other critical supplies to support healthcare initiatives across multiple federal agencies. Another notable IDV is with the Centers for Disease Control and Prevention, specifically for adult vaccines. This $121.9 million contract, running from July 2024 to June 2025, covers a variety of adult vaccines including those for Hepatitis, HPV, Meningococcal, and Pneumococcal diseases. These IDVs demonstrate Pfizer's critical role in supplying pharmaceuticals and vaccines to support wide-ranging government healthcare programs, from combat readiness to public health initiatives.
MHBQULRMEEJ5 325412
Not listed 66 Hudson Blvd E, New York, NY 10001, USA
1/30/02 8/13/25 Glaxosmithkline, LLC
Glaxosmithkline, LLC, doing business as Glaxosmithkline, is a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies through federal contract and grant awards.
Glaxosmithkline has provided a range of pharmaceutical goods and services as the prime contractor on federal contracts, including influenza virus and hepatitis vaccines, COVID-19 treatments, vaccine adjuvants, and antiviral medications like zanamivir and sotrovimab. Major customers include the Departments of Defense, Veterans Affairs, Health and Human Services, State, and Justice. Awards have supported disease prevention efforts, immunization programs, drug stockpiling initiatives, and correctional facility healthcare services. Contracts have been issued on a firm fixed price basis, with no set-aside designations and performance generally occurring at Glaxosmithkline’s North Carolina facilities. The company has also partnered as a subcontractor supporting distribution and logistics services on a $280 million Department of Defense contract for COVID-19 monoclonal antibody therapeutics.
Glaxosmithkline has received one federal grant subaward from Boston University to facilitate clinical development of a small molecule drug that targets E. coli bacteria adhesion in order to treat and prevent urinary tract infections. The phase 1 first-in-human safety and tolerability trial aims to provide data to support further development of this therapeutic candidate.
The company holds several federal contract indefinite delivery vehicles for pharmaceutical products and vaccines. These include a 5-year, $15 million contract with the VA National Acquisition Center to supply seasonal influenza vaccines, a 5-year, $3 million CDC contract for vaccine storage and rotation services, and a $4.6 million Defense Logistics Agency Troop Support contract to provide the antiviral medication zanamivir. Additional multiple award IDVs from the Centers for Disease Control and Prevention provide pooled contracts for purchasing pediatric and adult influenza vaccines as well as broader categories of vaccines to support routine immunization programs. Associated task orders further specify quantities and delivery timelines based on public health requirements.
FRHTPHMZMX47 325412
Not listed 410 Blackwell St, Durham, NC 27701, USA
10/25/10 1/15/26 Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC, doing business as Merck, is a major pharmaceutical manufacturer and supplier to the U.S. federal government. As a subsidiary of Schering Plough Corporation, Merck has been registered to receive federal awards since March 2011. The company provides a wide range of vaccines, drugs, and medical countermeasures to support public health initiatives and healthcare missions across multiple federal agencies. Merck's extensive portfolio includes products for the prevention and treatment of various diseases, including infectious diseases, cancer, and cardiovascular conditions. As a for-profit organization and manufacturer of goods, Merck has established itself as a critical partner in supplying essential pharmaceutical products to meet the diverse needs of government healthcare programs.
Through prime and sub federal contract awards, Merck has delivered an extensive array of pharmaceutical products and services. These include various vaccines such as MMR (measles, mumps, rubella), varicella, hepatitis, pneumococcal, tetanus, diphtheria, human papillomavirus, and meningococcal vaccines. The company has also supplied drugs like Welireg (belzutifan) for cancer treatment and molnupiravir as a COVID-19 antiviral. Major funding agencies include the Department of Veterans Affairs, Department of Defense, Department of Health and Human Services, and the Centers for Disease Control and Prevention. Merck has received numerous delivery orders under its Federal Supply Schedule contract for pharmaceuticals and drugs, primarily supporting civilian agencies like the VA and HHS. The company has also engaged in subcontracts related to COVID-19 vaccine development with partners such as the International AIDS Vaccine Initiative. Notably, Merck's federal contract awards do not typically involve set-aside designations.
Merck holds several significant indefinite delivery vehicles (IDVs) with federal agencies, primarily focused on vaccine supply and related services. The company has multiple IDVs with the Centers for Disease Control and Prevention for both adult and pediatric vaccines, with potential values ranging from $69 million to over $4 billion. These contracts support critical immunization programs such as the Vaccines for Children program and adult vaccination initiatives under Section 317(j) of the Public Health Service Act. Merck also holds an IDV for vaccine storage and rotation services with the CDC, valued at $13 million. Additionally, the company has a Blanket Purchase Agreement with the Department of Veterans Affairs for the supply of Welireg, with a $15 million ceiling. These IDVs enable agencies to flexibly order a wide range of vaccines and pharmaceutical products from Merck over multi-year periods, ensuring a reliable supply chain for essential medications and immunizations across the United States.
FCFDA78HKKG2 325412
Not listed 126 E Lincoln Ave, Rahway, NJ 07065, USA
3/9/11 5/7/25 Sanofi Pasteur Inc.
Sanofi Pasteur Inc. is a corporate entity that provides vaccines, pharmaceuticals, medical supplies, and related services to U.S. government agencies through federal contract awards. According to its website, Sanofi Pasteur Inc. operates as a trusted source for vaccines, medical supplies, patient resources and office management tools for healthcare professionals.
As the prime contractor, Sanofi Pasteur Inc. has provided a range of vaccine products and services to federal agencies including the Department of Veterans Affairs, Indian Health Service, Centers for Disease Control and Prevention, Defense Logistics Agency, Department of Health and Human Services, Department of Justice Bureau of Prisons, Smithsonian Institution, and Department of State. These have included seasonal and pre-pandemic influenza vaccines, pneumonia vaccines, meningitis vaccines, yellow fever vaccines and other standard immunizations to support disease prevention and maintain public health preparedness. Awards have been made on a firm fixed price basis without set aside designations, with performance occurring at Sanofi Pasteur's Swiftwater, Pennsylvania facility or other designated locations to fulfill agency requirements.
Sanofi Pasteur Inc. holds several Indefinite Delivery Vehicles to provide pharmaceutical products and vaccines through task orders from various agencies. These include a 5-year IDIQ from the HHS Office of the Assistant Secretary for Preparedness and Response potentially valued at $5.87 billion to supply medical countermeasures for emerging health threats. Sanofi Pasteur also holds a place on a $634 million Pharmaceuticals and Drugs Federal Supply Schedule enabling streamlined ordering of vaccines and critical drugs. Additionally, the firm has received CDC and DLA Troop Support awards to supply adult, pediatric and military influenza vaccines over 1 to 5 year IDV periods with potential values ranging from $47 million to $2.4 billion. The IDVs leverage Sanofi Pasteur's manufacturing capabilities and distribution infrastructure to facilitate efficient fulfillment of agency requirements for vaccines and pharmaceuticals supporting public health missions.
NCXBGGQ8YTU9 325414
Not listed 1 Discovery Dr, Swiftwater, PA 18370, USA
1/2/02 11/1/25 Grifols USA LLC
Grifols USA LLC is a global healthcare company specializing in the development, manufacturing, and distribution of plasma-derived medicines, transfusion medicine products, and pharmaceutical supplies. Registered in the System for Award Management (SAM) since 2001, the company is a for-profit organization and manufacturer of goods that provides critical pharmaceutical products to various federal agencies. As a large business with extensive experience in healthcare and pharmaceutical manufacturing, Grifols has established itself as a key supplier of specialized medical products to the U.S. government.
Through its federal contract awards, Grifols has primarily supplied specialized pharmaceutical products, with a significant focus on PROLASTIN-C, an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency. The company has consistently been awarded contracts by civilian agencies, particularly the Department of Veterans Affairs (VA), Department of Justice's Bureau of Prisons, and the Centers for Disease Control and Prevention (CDC). These contracts have been predominantly firm fixed-price delivery orders and purchase orders, ranging from small-scale orders of approximately $7,000 to larger contracts exceeding $500,000. None of the contracts examined featured set-aside designations, reflecting Grifols' capability to compete effectively in the federal marketplace as a large business.
Grifols holds several significant indefinite delivery contracts (IDVs), most notably a $1.38 billion Federal Supply Schedule contract with the VA for Pharmaceuticals and Drugs and multiple contracts with the CDC for vaccine supply. These IDVs include a $107.5 million Blanket Purchase Agreement specifically for PROLASTIN-C and several annual contracts for pediatric and adult vaccines. The CDC contracts, valued between $1.6 million and $13.8 million annually, cover a wide range of vaccines including DTaP, hepatitis, HPV, MMR, pneumococcal, and rotavirus vaccines. These IDVs enable federal agencies to efficiently procure essential pharmaceutical products and vaccines through competitive task order procedures, demonstrating Grifols' critical role in supporting federal healthcare and immunization programs.
D48FNWJCJ5H5 325412
Not listed 2410 Grifols Wy, Los Angeles, CA 90032, USA
8/8/01 11/26/25